EGFR and non-small cell lung carcinoma: Compared with the control group, the serum level of EGFR in NSCLC patients was stimulated, and the level in the NSCLC-terminal group was further facilitated relative to that in the NSCLC-early group (P < 0.001, Figure 5b).